BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2014 5:08:00 PM | Browse: 1034 | Download: 1055
Publication Name World Journal of Gastroenterology
Manuscript ID 11029
Country China
Received
2014-05-01 09:23
Peer-Review Started
2014-05-02 11:38
To Make the First Decision
2014-05-29 19:01
Return for Revision
2014-06-12 12:21
Revised
2014-07-05 00:00
Second Decision
2014-09-16 13:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-09-16 13:47
Articles in Press
2014-09-16 13:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-09-30 07:15
Typeset the Manuscript
2014-12-04 17:38
Publish the Manuscript Online
2014-12-18 17:08
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Jia-Yan Ni, Hong-Liang Sun, Yao-Ting Chen, Jiang-Hong Luo, Dong Chen, Xiong-Ying Jiang and Lin-Feng Xu
Funding Agency and Grant Number
Corresponding Author Lin-Feng Xu, MD, PhD, Chief, Department of Interventional Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang Road West, Guangzhou 510120, Guangdong Province, China. xu_lin_feng@163.com
Key Words Hepatocellular carcinoma; Transarterial chemoembolization; Microwave ablation; Survival; Prognosis
Core Tip Transarterial chemoembolization (TACE) combined with microwave ablation (MWA) has been used more and more widely for treatment of patients with hepatocellular carcinoma (HCC). However, there has been no study designed to analyze prognostic factors for survival after TACE combined with MWA for HCC. In this study, we retrospectively collected clinicopathologic data of 86 patients who were treated by TACE sequentially combined with MWA, and to analyze prognostic factors for survival after the combinational therapy. We hope that our finding could serve as significant information for clinicians and patients in the decision for selecting treatment strategies.
Publish Date 2014-12-18 17:08
Citation Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490
URL http://www.wjgnet.com/1007-9327/full/v20/i46/17483.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i46.17483
Full Article (PDF) WJG-20-17483.pdf
Full Article (Word) WJG-20-17483.doc
Manuscript File 11029-Review.doc
Answering Reviewers 11029-Answering reviewers.pdf
Copyright License Agreement 11029-Copyright assignment.pdf
Peer-review Report 11029-Peer reviews.pdf
Scientific Misconduct Check 11029-CrossCheck.jpg
Scientific Editor Work List 11029-Scientific editor work list.pdf